Please use this identifier to cite or link to this item:
https://doi.org/10.1111/cpr.12913
DC Field | Value | |
---|---|---|
dc.title | Essential functions of miR-125b in cancer | |
dc.contributor.author | Peng, Boya | |
dc.contributor.author | Theng, Poh Ying | |
dc.contributor.author | Le, Minh T. N. | |
dc.date.accessioned | 2022-10-13T07:58:35Z | |
dc.date.available | 2022-10-13T07:58:35Z | |
dc.date.issued | 2020-12-17 | |
dc.identifier.citation | Peng, Boya, Theng, Poh Ying, Le, Minh T. N. (2020-12-17). Essential functions of miR-125b in cancer. Cell Proliferation 54 (2) : e12913. ScholarBank@NUS Repository. https://doi.org/10.1111/cpr.12913 | |
dc.identifier.issn | 0960-7722 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/233282 | |
dc.description.abstract | MicroRNAs (miRNAs) are small and highly conserved non-coding RNAs that silence target mRNAs, and compelling evidence suggests that they play an essential role in the pathogenesis of human diseases, especially cancer. miR-125b, which is the mammalian orthologue of the first discovered miRNA lin-4 in Caenorhabditis elegans, is one of the most important miRNAs that regulate various physiological and pathological processes. The role of miR-125b in many types of cancer has been well established, and so here we review the current knowledge of how miR-125b is deregulated in different types of cancer; its oncogenic and/or tumour-suppressive roles in tumourigenesis and cancer progression; and its regulation with regard to treatment response, all of which are underlined in multiple studies. The emerging information that elucidates the essential functions of miR-125b might help support its potentiality as a diagnostic and prognostic biomarker as well as an effective therapeutic tool against cancer. © 2020 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd | |
dc.publisher | Blackwell Publishing Ltd | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus OA2021 | |
dc.subject | biomarker | |
dc.subject | cancer | |
dc.subject | chemoresistance | |
dc.subject | microRNA | |
dc.subject | miR-125b | |
dc.type | Review | |
dc.contributor.department | DEPT OF BIOCHEMISTRY | |
dc.contributor.department | DEPT OF PHARMACOLOGY | |
dc.description.doi | 10.1111/cpr.12913 | |
dc.description.sourcetitle | Cell Proliferation | |
dc.description.volume | 54 | |
dc.description.issue | 2 | |
dc.description.page | e12913 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1111_cpr_12913.pdf | 1.48 MB | Adobe PDF | OPEN | None | View/Download |
SCOPUSTM
Citations
23
checked on Jan 22, 2023
Page view(s)
15
checked on Jan 26, 2023
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License